Phreesia (NYSE:PHR) & Valion Bio, Inc. Common Stock (NASDAQ:VBIO) Head-To-Head Contrast

Phreesia (NYSE:PHR) and Valion Bio, Inc. Common Stock (NASDAQ:VBIO) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, profitability, earnings, dividends and valuation.

Profitability

This table compares Phreesia and Valion Bio, Inc. Common Stock’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Phreesia	0.48%	3.23%	2.11%
Valion Bio, Inc. Common Stock	N/A	-109.83%	-69.32%

Valuation and Earnings

This table compares Phreesia and Valion Bio, Inc. Common Stock”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Phreesia	$480.59 million	1.22	$2.31 million	$0.03	322.10
Valion Bio, Inc. Common Stock	$780,000.00	4.07	-$8.88 million	N/A	N/A

Phreesia has higher revenue and earnings than Valion Bio, Inc. Common Stock.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Phreesia and Valion Bio, Inc. Common Stock, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Phreesia	1	6	12	0	2.58
Valion Bio, Inc. Common Stock	1	0	0	0	1.00

Phreesia currently has a consensus target price of $20.82, indicating a potential upside of 115.50%. Given Phreesia’s stronger consensus rating and higher possible upside, analysts clearly believe Phreesia is more favorable than Valion Bio, Inc. Common Stock.

Volatility and Risk

Phreesia has a beta of 0.89, indicating that its stock price is 11% less volatile than the S&P 500. Comparatively, Valion Bio, Inc. Common Stock has a beta of 1.86, indicating that its stock price is 86% more volatile than the S&P 500.

Insider and Institutional Ownership

92.1% of Phreesia shares are owned by institutional investors. Comparatively, 4.3% of Valion Bio, Inc. Common Stock shares are owned by institutional investors. 5.5% of Phreesia shares are owned by insiders. Comparatively, 2.4% of Valion Bio, Inc. Common Stock shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Phreesia beats Valion Bio, Inc. Common Stock on 10 of the 12 factors compared between the two stocks.

About Phreesia

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.

About Valion Bio, Inc. Common Stock

Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.